Skip to main content
Chemfab Alkalis Ltd logo

Chemfab Alkalis Ltd — Investor Relations & Filings

Ticker · CHEMFAB ISIN · INE783X01023 LEI · 3358001VZX74GFCTZW69 BSE.NS Manufacturing
Open in API
Filings indexed 392 across all filing types
Latest filing 2022-01-06 Regulatory Filings
Country IN India
Listing BSE.NS CHEMFAB

About Chemfab Alkalis Ltd

https://chemfabalkalis.com/

Chemfab Alkalis Ltd is a chemical manufacturing enterprise specializing in the chlor-alkali sector. The company primarily produces caustic soda (sodium hydroxide) in both lye and flake forms, alongside co-products such as liquid chlorine, hydrochloric acid, sodium hypochlorite, and compressed hydrogen gas. Notably, the organization was a pioneer in implementing energy-efficient membrane cell technology in its production processes. Its product portfolio serves diverse industrial applications, including water treatment, textile processing, paper and pulp manufacturing, aluminum refining, and the production of soaps and detergents. The company emphasizes operational efficiency and environmental compliance through advanced electrolysis techniques and rigorous quality control measures.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate submitted under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2011. It is addressed to stock exchanges and signed by the company secretary. The document is short (1353 characters) and serves as a certification or confirmation letter rather than a full financial report or detailed filing. It does not contain financial data or detailed report content but is a regulatory compliance submission. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2022-01-06 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice from Chemfab Alkalis Limited informing the stock exchanges about an upcoming Board Meeting scheduled for January 31, 2022. The purpose of the meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2021. The document also mentions the closure of the trading window in compliance with SEBI regulations. The document is short (1791 characters) and serves as an announcement of a future event (Board Meeting) rather than containing the financial results or detailed report itself. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as a general announcement related to compliance and scheduling of financial results approval.
2022-01-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the closure of the trading window pursuant to SEBI regulations on insider trading. It mentions the trading window closure period related to the declaration of unaudited financial results but does not contain any financial data or results itself. The document is short (1474 characters) and serves as a regulatory announcement rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements.
2021-12-30 English
Trading Plan under PIT
Regulatory Filings
2021-11-02 English
Financial Result Updates
Regulatory Filings
2021-10-29 English
Outcome of Board Meeting
Regulatory Filings
2021-10-29 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.